Apontis Pharma AG (APPH) — Net Asset Quality Index
Apontis Pharma AG (APPH) has a Net Asset Quality Index of 71.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €43.99 Million minus total liabilities of €12.37 Million yields net assets of €31.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Apontis Pharma AG (APPH) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Apontis Pharma AG Net Asset Quality Index Over Time (2018–2024)
This chart shows how Apontis Pharma AG's Net Asset Quality Index has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the index stands at 71.9%, representing net assets of €31.62 Million against total assets of €43.99 Million EUR. For live market cap and overall valuation, see Apontis Pharma AG (APPH) market capitalisation.
Annual Net Asset Quality Index for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Net Asset Quality Index for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Apontis Pharma AG (APPH) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.9% | €31.02 Million | €44.37 Million | €13.36 Million | ▲ +17.2 pp |
| 2023 | 52.7% | €30.26 Million | €57.46 Million | €27.20 Million | ▼ -16.8 pp |
| 2022 | 69.4% | €41.57 Million | €59.85 Million | €18.29 Million | ▼ -5.8 pp |
| 2021 | 75.2% | €40.71 Million | €54.13 Million | €13.42 Million | ▲ +63.6 pp |
| 2020 | 11.6% | €3.46 Million | €29.69 Million | €26.23 Million | ▼ -3.5 pp |
| 2019 | 15.2% | €4.64 Million | €30.59 Million | €25.94 Million | ▼ -5.0 pp |
| 2018 | 20.2% | €7.03 Million | €34.84 Million | €27.81 Million | — |